That leads to thousands upon thousands of unnecessary biopsies every year. (The test is guilty of false negatives, too: PSA fails to spot cancer 15% of the time.) Moreover, up to 75% of prostate tumors being detected now by PSA are too small to be an immediate threat, asserts Stanford University urologist Thomas Stamey.

FORBES: Men, Cancer & Hope